The current institutional shareholding score of Centessa Pharmaceuticals PLC is 10.00, ranking 1 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 97.10%, representing a quarter-over-quarter decrease of 2.28%. The largest institutional shareholder is Lee Ainslie, holding a total of 1.85M shares, representing 1.20% of shares outstanding, with 0.13% increase in holdings.